U-Chart Analysis:ZERIA PHARMACEUTICAL CO.,LTD.:4559

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index ZERIA PHARMACEUTICAL CO.,LTD. Go to web site 4559 Medicals 東証プライム March 1, 2000 1998.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

ZERIA PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ZERIA PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents 16,219 11,704 9,794 9,005 8,045
Other Current AssetsHelp 31,985 29,959 27,520 26,015 30,678
Tangible Fixed AssetsHelp 24,591 23,139 23,634 23,125 22,914
Intangible Fixed AssetHelp 8,473 7,836 7,690 7,309 7,005
Investments and OthersHelp 20,309 18,273 18,842 16,162 18,998
Total AssetsHelp 135,035 124,282 121,860 104,156 110,434
Total Current LiabilitiesHelp 55,043 51,002 60,056 46,175 43,452
Total Long-term LiabilitiesHelp 14,541 18,386 5,820 5,471 7,796
Shareholder's EquityHelp 65,450 54,895 55,985 52,510 59,186
Total LiabilitiesHelp 135,035 124,282 121,860 104,156 110,434

ZERIA PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ZERIA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales 68,383 59,533 55,442 60,427 61,832
Total Sales 68,383 59,533 55,442 60,427 61,832
Cost of SalesHelp 18,895 17,385 15,796 16,644 17,753
Other Costs and RevenueHelp 43,293 38,187 36,502 40,858 40,625
Total CostsHelp 62,187 55,572 52,299 57,501 58,377
Net RevenueHelp 49,489 42,148 39,646 43,783 44,079
Earnings Before TaxHelp 7,273 5,722 3,957 3,920 5,221
Net IncomeHelp 6,196 3,961 3,143 2,925 3,454
Net Income 6,196 3,961 3,143 2,925 3,454

ZERIA PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ZERIA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期 ZERIA PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help 13,157 9,080 6,894 7,295 5,501
Investing Cash Flow(ICF)Help -2,575 -2,893 -17,461 -405 -2,856
Financing Cash FlowHelp -7,415 -4,841 11,185 -5,878 -4,535
Exchange Difference of Cash and Cash EquivalentsHelp 1,347 564 170 -52 -225
Net Increase and Decrease in Cash and Cash Equivalentsn 4,515 1,910 789 960 -2,115

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

ZERIA PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

Sanko Junyaku Co.,Ltd.
Cuorips Inc.
StemRIM Inc.
Otsuka Holdings Co.,Ltd.
Carna Biosciences,Inc.
RIBOMIC Inc.
WAKAMOTO PHARMACEUTICAL CO.,LTD.
SanBio Company Limited
Shionogi & Co.,Ltd.
KAINOS Laboratories,Inc.